Cargando…
Pharmacometabolomics Profiling of Preterm Infants Validates Patterns of Metabolism Associated With Response to Dexamethasone Treatment for Bronchopulmonary Dysplasia
Bronchopulmonary dysplasia (BPD) is one of the most common health complications of premature birth. Corticosteroids are commonly used for treatment of BPD, but their use is challenging due to variability in treatment response. Previous pharmacometabolomics study has established patterns of metabolit...
Autores principales: | Stockard, Bradley, Gauldin, Cheri, Truog, William, Lewis, Tamorah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226475/ https://www.ncbi.nlm.nih.gov/pubmed/35757122 http://dx.doi.org/10.3389/fped.2022.898806 |
Ejemplares similares
-
Pharmacometabolomics of Respiratory Phenotypic Response to Dexamethasone in Preterm Infants at Risk for Bronchopulmonary Dysplasia
por: Lewis, Tamorah, et al.
Publicado: (2019) -
Genetic Variation in CRHR1 is Associated with
Short-Term Respiratory Response to Corticosteroids in Preterm Infants at risk
for Bronchopulmonary Dysplasia
por: Lewis, Tamorah, et al.
Publicado: (2018) -
Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
por: Rivera, Lidys, et al.
Publicado: (2016) -
Comparing low-dose (DART) and enhanced low-dose dexamethasone regimens in preterm infants with bronchopulmonary dysplasia
por: Al-taweel, Heba Mohamed, et al.
Publicado: (2023) -
Risk Factors for Tracheobronchomalacia in Preterm Infants With Bronchopulmonary Dysplasia
por: Su, Ya-Ting, et al.
Publicado: (2021)